Sysmex is introducing their next-generation haemostasis solution featuring the CN-Series analysers*, designed to answer the evolving challenges in haemostasis labs to support swift diagnoses and therapy monitoring.
This webinar series will provide first-hand experience on two models of the CN-Series: CN-6000, Sysmex’s latest high-volume, fully automated haemostasis analyser and, as a sneak preview of the future, another model of the new haemostasis analyser series, CN-6500, with an integrated chemiluminescent enzyme immunoassay (CLEIA) testing capability.
Our speakers will address the outcomes of the performance evaluations on Sysmex’s new CN-Series instruments.
Dr Ian Mackie, Reader in Haemostasis and Thrombosis, Research Haematology Dept., University College London, London, UK
Dr Ian Mackie is Emeritus Reader in Haemostasis and Thrombosis at University College London. He set up the Haemostasis Research Unit at The Middlesex Hospital and UCL with Sam Machin over 35 years ago.
He is a past President of the British Society for Haemostasis and Thrombosis, a board member of the International Council for Standardization in Hematology and Co-Editor of the International Journal for Laboratory Hematology. He has served on the UK NEQAS Steering Committee and the British Committee for Standards in Haematology, Haemostasis and Thrombosis Task Force. His main interests are in haemostasis, particularly antiphospholipid antibodies, ADAMTS13, abnormalities of the complement system and the development of new haemostasis methods, and he has over 200 peer review publications.
First speaker: Dr Steve Kitchen, Clinical Scientist, Department of Coagulation, Royal Hallamshire Hospital, Sheffield S10 2JF, UK
Dr Steve Kitchen is currently Lead Clinical Scientist, Dept of Coagulation, Sheffield Haemophilia and Thrombosis Centre, Sheffield Teaching Hospitals. The centre is designated an International Haemophilia Training Centre by World Federation of Haemophilia. He has been Scientific Director for the UK National External Quality Assessment Scheme for Blood Coagulation since 2001 and a Director WFH for the International External Quality Assessment Schemes for Blood Coagulation since 2012.
With over 35 years’ experience in the field of laboratory testing in haemostasis, Steve is active within committees and working groups such as the Steering Committee UK NEQAS Blood Coagulation (since 1992), World Federation of Haemophilia, Laboratory Sciences Committee (since 1993), SSC Working Group on Diagnostic Standards (since 1995) and ICSH Vice chair Haemostasis (since 2016).
Second speaker: Dr Chris Gardiner, Director, Chris Gardiner Consulting Ltd, Bucks HP17 8LG, UK
Dr Chris Gardiner trained as a biomedical scientist at North Tyneside District General Hospital beginning in 1984 and gained Fellow of the Institute of Biomedical Sciences in Haematology in 1990. For most of his career, Chris has specialised in haemostasis and ran the UK Department of Health evaluation programme for coagulometers, haemostasis tests and point of care coagulation devices at University College London Hospital for 12 years. He completed his doctorate in 2008 and was admitted as a Fellow of the Royal College of Pathologists in 2017. His research interests include the antiphospholipid syndrome, venous thromboembolism, pre-eclampsia and extracellular vesicles. He has published over 60 peer reviewed papers and several international guidelines and is currently leading an International Council for Standardization in Haematology working group on evaluation of haemostasis test systems.
*Availability of product depends on regulatory approval in each country
Table of Content
Dr Kitchen will share his first-hand experience on CN-6000 to answer the question ‘Does the CN-Series have the potential of powering up your laboratory?
Dr Gardiner will present his findings on another CN-Series model, CN-6500, a new haemostasis analyser with an integrated CLEIA testing capability.